Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven StatesPHILADELPHIA - - Partnership With Elsevier Continues Tradition of Excellence in Serving Healthcare Needs of Patients in California, Idaho, Indiana, Iowa, Maryland, Michigan and Ohio SAE International Releases Test Results of the Low GWP Refrigerant for Mobile Air-ConditioningWARRENDALE, Pennsylvania, November 10 - A Cooperative Research Program conducted through SAE International to EnerSys to Purchase Oerlikon Battery BusinessREADING, Pennsylvania - EnerSys (NYSE: ENS) the world’s largest manufacturer, marketer and distributor of industrial batteries announced today that it has signed a definitive agreement to acquire the industrial battery businesses of the Swiss company Accu Holding AG (SIX: ACUN). The transaction is subject to approval by the general assembly of Accu Holding. An extraordinary meeting of the general assembly is scheduled for November 24, 2009 after which the transaction is scheduled to close. Thomson Reuters Chosen to Support World University RankingsPHILADELPHIA and LONDON - - Data Quality And Analysis Primary Factors In Selection Thomson Reuters, the authority on research citation data for more than half a century, announced today that it will be the sole provider of data used to calculate the annual World University Rankings produced by the Times Higher Education. Patenting Mother Nature: Thomson Reuters World IP Today Report Reveals Wind Technology Leading Alternative Energy FieldPHILADELPHIA - - Intellectual property analysis tracks patenting activity in wind, solar and marine power globally; smaller, niche companies are the most active Video: One Shot of Gene Therapy and Children with Congenital Blindness Can Now SeePHILADELPHIA - Born with a retinal disease that made him legally blind, and would eventually leave him totally sightless, the nine-year-old boy used to sit in the back of the classroom, relying on the large print on an electronic screen and assisted by teacher aides. Now, after a single injection of genes that produce light-sensitive pigments in the back of his eye, he sits in front with classmates and participates in class without extra help. In the playground, he joins his classmates in playing his first game of softball. Cohera Medical, Inc. Receives Approval To Begin Human Clinical Trials of TissuGlu(R) in EuropePITTSBURGH - Cohera Medical, Inc. announced today that it has received approval to begin human clinical trials of its lead product TissuGlu(R) in Germany. Receipt of the approval allows Cohera Medical to proceed with patient recruitment and initiation of an investigational study of the company’s novel internal surgical adhesive being developed for its first intended use to adhere surgical tissues together in large flap surgeries. Unirisx Names Marion Madden Non-Executive Chairman, London MarketsPHILADELPHIA and LONDON - - Leading Global SaaS Insurance Software Provider Hires Former R J Kiln & Co. Ltd., COO to Expand Services in the UK Tube City IMS Receives 31 Safety Awards from National Slag AssociationPITTSBURGH - Tube City IMS, LLC, a leading provider of products and services to steel mills and foundries globally, today announced that several of the Company’s sites received a total of 31 Safety Awards from the National Slag Association (NSA) for 2008. Food and Drug Administration Expert to Deliver Keynote AddressWARRENDALE, Pennsylvania - - Jay Crowley to Speak at Track & Trace Virtual Trade Show UBM International Media, a wholly owned subsidiary of United Business Media plc (LSE: UBM) and AIM, the international association and recognized authority on bar code, RFID, and enterprise mobile computing, today announced that the FDA’s Jay Crowley, senior advisor for patient safety, Center for Devices and Radiological Health, will deliver the keynote address for the Track & Trace Virtual Trade Show on opening day, December 2nd in the online presentation theater. Chatham Financial Testifies Before the House Financial Services Committee Hearing on OTC Derivatives LegislationKENNETT SQUARE, Pennsylvania - Chatham Financial, the largest independent interest rate and foreign exchange risk management advisor, testified before the House Financial Services Committee hearing on derivatives legislation. Chatham was invited by the Committee as an independent expert to testify as a representative of business end users who use derivatives to reduce their interest rate, foreign currency and commodity price risk. Chatham’s Chief Operating Officer, Dave Hall, testified on the merits and concerns in the currently drafted legislation released Friday by Chairman Barney Frank and the House Financial Services Committee. Coventry, NY Attorney General, Agree to SettlementFORT WASHINGTON, Pennsylvania - - Agreement Outlines Industry Best Practices; No Fine or Penalty Assessed Dubai Group Statement in Response to Announcement by Bank Islam Malaysia BerhadDUBAI, United Arab Emirates - “Following an earlier announcement by BIMB Holdings Berhad BHB (”Bank Islam”) with regards to its April 2009 offer for the capital increase, Dubai Group confirms that it is in the process of reviewing its strategic options relating to its stake. Bank Islam boasts strong attributes across the Asian banking sector, and the capital raise offer came in reflection of the successful transformation plan implemented by Bank Islam since 2006. However, following the reassessment of its investment strategy, Dubai Group has redirected its competitive advantage closer to home, namely the GCC and greater Middle East regions. Malaysia does remain a key market for future investments.” CDI Corp. Announces Decision in OFT InvestigationPHILADELPHIA - CDI Corp. (NYSE: CDI) today announced that the United Kingdom’s Office of Fair Trading (”OFT”) has issued a decision in its investigation into alleged anti-competitive behavior by CDI’s U.K.-based subsidiary, AndersElite (”Anders”). Innovative Systems’ New Strategy Focuses on Cross-Product Line Solutions to Achieve Client ObjectivesPITTSBURGH - Innovative Systems, Inc. (ISI), a leading provider of data quality, customer data integration, business intelligence support and regulatory compliance solutions worldwide today announced its new strategy to deliver compliance, data quality and customer connectivity in a common platform. This new strategy is reflected in ISI’s new Web site, recently launched at www.innovativesystems.com. Stephen W. Borron, M.D., Named Medical Editor-In-Chief of ToxEDPHILADELPHIA - Elsevier, the leading publisher of scientific, technical and medical information announced today that, the Stephen W. Borron, M.D., has been named Medical Editor-in-Chief of ToxED (www.toxed.com/), an online clinical toxicology reference that provides clinicians with quick access to concise and comprehensive drug, poison and chemical information at the point-of-care. pcGAMESTORE.com Announces the Launch of a Buy One - Get 50% Discount Coupon and a Chance to Win a High End Gaming PCPHILADELPHIA - - Purchasers can buy as often as they like. Get a coupon for future purchases equal to 50% of the purchased game price Wyeth Receives Positive Opinion from European Regulators for its 13-valent Pneumococcal Candidate Vaccine for Infants and Young ChildrenCOLLEGEVILLE, Pennsylvania - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the company’s pneumococcal conjugate vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent Adsorbed]). The CHMP recommends approval of Prevenar 13 for active immunization of children aged 6 weeks to 5 years for the prevention of invasive pneumococcal disease, as well as pneumonia and otitis media (middle ear infection) caused by 13 pneumococcal serotypes. The CHMP’s opinion for Prevenar 13 will now be forwarded to the European Commission and a final decision is expected in the coming months. 30th Anniversary Edition of Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases is More Relevant Than EverPHILADELPHIA, Pennsylvania - - Highly Respected Text Addresses New Strains of the Swine (H1N1) and Avian Influenza Viruses. Tube City IMS’ Belgium Subsidiary Achieves VCA Certification; France Subsidiary Receives OHSAS 18001 CertificationPITTSBURGH - Tube City IMS, a provider of products and services to steel mills and foundries throughout the world, today announced the Company’s subsidiary’s facility in Gent, Belgium has achieved VCA certification and its facility in Fos Sur Mer, France has achieved Occupational Health and Safety Assessment Series (OHSAS) 18001 certification. Coventry Spins Off Top-Ranked Servicing Unit: Launches Montgomery Portfolio ServicesFORT WASHINGTON, Pennsylvania - Coventry announced the launch of Montgomery Portfolio Services today, providing institutional owners of longevity-linked portfolios with access to the industry’s leading servicing platform. Cognizant Deploys IT Infrastructure Services at Rodale to Reduce Costs, Increase Efficiency, Improve Customer ExperienceTEANECK, New Jersey and EMMAUS, Pennsylvania - - Global Media Company Leverages Cognizant’s Advanced RIM 2.0 Remote Infrastructure Management Platform to Ensure Service Quality Excellence Wyeth Presents Data from Five-Year Vertebral Fracture Prevention Study with BazedoxifeneCOLLEGEVILLE, Pennsylvania - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announces findings from a placebo-controlled Phase 3 study of bazedoxifene 20 mg extended to five years, which indicated a significant reduction versus placebo in new vertebral fractures in postmenopausal women with osteoporosis. These and other data were presented at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting in Denver, Colo. Bazedoxifene, a selective estrogen receptor modulator (SERM), is under clinical investigation for the prevention and treatment of postmenopausal osteoporosis. Pittsburgh Welcomes the World With Art and LightPITTSBURGH - - Duquesne Light and The Pittsburgh Cultural Trust Showcase Region’s Transformation with the ‘Pittsburgh Festival of Lights’ Important Notice: Not For Distribution In Or Into, Or To Any Person Located Or Resident In Or At Any Address In, The Republic Of ItalyPHILADELPHIA - - Crown Holdings, Inc. Announces Final Results of Tender Offer for Any and All First Priority Senior Secured Notes Due 2011 Emirate of Sharjah’s Directorate of Town Planning and Survey Deploys Bentley’s Cadastral Solution to Streamline WorkflowsEXTON, Pennsylvania - - Moves to Bentley Geospatial Server for Enterprise GIS and Bentley Cadastre for Data Editing Prescient Medical Inc. Featured on FOX Business NetworkDOYLESTOWN, Pennsylvania - Prescient Medical Inc. announced that CEO Patricia Scheller, appeared on FOX Business Network (FBN) to discuss the company’s groundbreaking products and recent achievement of CE Mark approval for their vProtect(TM) Luminal Shield Stent System. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership AwardTEL AVIV, Israel and SOUTHAMPTON, Pennsylvania - Mennen Medical, a leading provider of patient monitors, cardiac catheterization and electrophysiology systems, announced today that the global growth consulting company Frost & Sullivan has awarded Mennen Medical the 2009 European Patient Monitoring Technology Leadership of the Year Award. vProtect Luminal Shield (TM) from Prescient Medical Receives CE MarkDOYLESTOWN, Pennsylvania - - Novel Self-Expanding Platform for Treatment of Coronary Artery Disease Receives European Regulatory Clearance Nurses to Benefit From New CMS Never Events Resource Area on Mosby’s Nursing ConsultPHILADELPHIA, Pennsylvania - - Nursing Consult Feature Empowers Nurses to Improve Patient Care, Help Prevent Costly Mistakes; Hospitals Benefit From Averting the Reimbursement Losses FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and AdolescentsPHILADELPHIA - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has received a Complete Response letter today for INTUNIV(TM) (guanfacine) Extended Release from the Food and Drug Administration (FDA). This decision comes following labeling discussions with the FDA that did not result in agreement in time to meet the PDUFA date. First Intra-Operable Software for Intelligent Substation Design Speeds Project Delivery and Reduces CostsEXTON, Pennsylvania - - Bentley Substation V8i Provides Intelligent Information Models, Broad Range of Tools, and Integrated Electrical and Physical Design Workflows for Substations Digitas Health Expands Adding Two Key LocationsPHILADELPHIA - - Expansion to Meet Market Demand for Next Generation Agency Model in Healthcare Build Web, Mobile, and Desktop Applications with Speed and StylePITTSBURGH - - Components for all layers of application development inside ComponentOne Studio Enterprise 2009 v2 Wyeth’s Prevenar 13* Receives First ApprovalCOLLEGEVILLE, Pennsylvania - - Chile Grants First Approval of Prevenar 13 for the Prevention of Pneumococcal Disease in Infants and Children- |
